Nuvectis Pharma Inc. (NVCT)
Market Closed
22 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
16. 53
+2.71
+19.6093%
$
366.58M Market Cap
- P/E Ratio
- Div Yield
408,073 Volume
-1.52 Eps
$ 13.82
Previous Close 
Want to track NVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nuvectis Pharma Inc. (NVCT) Statistics
Valuation metrics
Market Cap 366.58M
Enterprise value 341.45M
Trailing P/E (ttm) -11.91
Forward P/E -
PEG ratio 0.66
Price/Sales (ttm) -
Price/Book (mrq) 22.76
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.17
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 147.07K
Average volume (90 days) 88.58K
Price summary
52-Week low 5.55
52-Week high 16.64
Beta -
50-Day moving average 10.64
200-Day moving average 8.79
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.07%
Return on equity -1.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.07
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.27%
Book value per share (mrq) 0.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
